Sirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patients With Blood Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Chronic Lymphocytic Leukemia
Related studies linked through entity extraction aliases.
Ofatumumab for High-Risk Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
- Status
- COMPLETED
- Phase
- PHASE2
Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE3
Phase II Trial of Revlimid® and Rituximab for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
- Status
- COMPLETED
- Phase
- PHASE2
Activity & Safety Study of Lenalidomide & Rituximab as Non-chemotherapy Based Therapy on Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Tandem Auto-Allo Transplant for Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Penostatin, Rituximab and Ontak and Allogeneic Natural Killer (NK) Cells for Refractory Lymphoid Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Dasatinib With Fludarabine and Rituximab in Relapsed and Refractory CLL and SLL
- Status
- TERMINATED
- Phase
- PHASE2
T-Regulatory Cell and CD3 Depleted Double Umbilical Cord Blood Transplantation in Hematologic Malignancies
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Safety and Tolerability of XmAb®5574 in Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Study of Hypoxia-Activated Prodrug TH-302 to Treat Advanced Leukemias
- Status
- COMPLETED
- Phase
- PHASE1
Open-Label Study of Lenalidomide in Combination With Oral Dexamethasone in the Treatment of Previously Untreated, Symptomatic Patients With Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Alternating Thalidomide and Lenalidomide Therapy Plus Rituximab (ThRiL) as Initial Treatment for Patients With CLL
- Status
- COMPLETED
- Phase
- PHASE2
Treatment of Chronic Lymphocytic Leukemia in Patients Previously Exposed to Rituximab
- Status
- COMPLETED
- Phase
- PHASE2
First in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects With Acute Myelogenous Leukemia and Selected B-cell Cancers
- Status
- COMPLETED
- Phase
- PHASE1
Rituximab Versus Observation as Maintenance Therapy in Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
- Status
- COMPLETED
- Phase
- PHASE3
Ofatumumab for Patients With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Characterization of Proliferating Compartment in B-Cell Patients and in Healthy Aging Subjects
- Status
- COMPLETED
- Phase
- N/A
Direct Measurement of Leukemic Cell Turnover (Synthesis and Removal) in Patients With Chronic Lymphocytic Leukemia (CLL) Using Deuterated Water
- Status
- COMPLETED
- Phase
- N/A
Bendamustine Hydrochloride Injection for Initial Treatment of Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2